Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis-Reference-Cited by-同舟云学术

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

Published:2020-04 Issue:4 Volume:72 Page:643-657
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hajarizadeh Behzad^ORCID,Cunningham Evan B.,Valerio Heather,Martinello Marianne^ORCID,Law Matthew,Janjua Naveed Z.^ORCID,Midgard Håvard,Dalgard Olav,Dillon John^ORCID,Hickman Matthew,Bruneau Julie,Dore Gregory J.,Grebely Jason^ORCID

Funder

Australian Government Department of Health and Ageing

Australian National Health and Medical Council

NHMRC

AbbVie

Cepheid

Gilead Sciences

Merck

Bristol-Myers Squibb

Boehringer Ingelheim

Janssen-Cilag

ViiV HealthCare

Roche

Gilead

Janssen

Publisher

Elsevier BV

Subject

Hepatology

Reference69 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

2. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs;Grebely;Addiction,2019

3. Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: the InC3 collaboration;Morris;Clin Infect Dis,2017

4. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: assessing barriers to hepatitis C prevention;Puzhko;Int J Drug Policy,2017

5. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017: protective effects of non-injecting drug use;Des Jarlais;Drug and Alcohol Dependence,2018

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis;Journal of Viral Hepatitis;2024-09-05

2. Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model;PLOS ONE;2024-08-29

3. Hepatitis C Virus Reinfection Among People Who Inject Drugs;JAMA Network Open;2024-08-26

4. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

5. Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs–A network modeling study;International Journal of Drug Policy;2024-08